вторник, 15 января 2008 г.

Trastuzumab: in her2 and hormone receptor co-positive metastatic breast cancer.

ARTICLE LINKS: TRASTUZUMAB: IN HER2 AND HORMONE RECEPTOR CO- METASTATIC CANCER.ADIS stimulant clear Drugs.2007.Jennifer S; Perry, Caroline M _ ABSTRACT: Trastuzumab is a humanised IgG1 monoclonal antibody, which selectively binds to the epidermal advance banker receptor 2 (HER2), inhibiting apartment build-up and survival in HER2-dependent tumours.
Read more Efficacy of laparoscopic ovarian drilling for polycystic ovary syndrome resistant to clomiphene citrate
Get more Combination therapy using fexofenadine, disodium cromoglycate, and a hypoallergenic amino acid-based formula induced remission in a patient with steroid-dependent, chronically active ulcerative colitis